Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Cost of Goods Sold

Aerie Pharmaceuticals Cost of Goods Sold Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Cost of Goods Sold from 2017 to 2020.
  • Aerie Pharmaceuticals Cost of Goods Sold for the quarter ending June 06, 2020 was $7m a -6.72% decrease of 0m year over year
  • Aerie Pharmaceuticals Cost of Goods Sold for the last 12 months ending June 06, 2020 was $32m a 14.39% increase of 5m year over year
  • Aerie Pharmaceuticals Annual Cost of Goods Sold for 2019 was $28m a 1.50% increase of 0m from 2018
  • Aerie Pharmaceuticals Annual Cost of Goods Sold for 2018 was $27m a 38.53% increase of 10m from 2017
  • Aerie Pharmaceuticals Annual Cost of Goods Sold for 2017 was $17m a 41.52% increase of 7m from 2016
Other Income Statement Metrics:
  • Aerie Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-51m a 21.13% decrease of -11m year over year
  • Aerie Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-51m a 20.91% decrease of -11m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Cost of Goods Sold Data

06/2020$7m
03/2020$8m
12/2019$8m
09/2019$8m
06/2019$7m
03/2019$5m
12/2018$8m
09/2018$7m
06/2018$7m
03/2018$5m

Annual AERI Cost of Goods Sold Data

2019$28m
2018$27m
2017$17m
2016$10m